17. Jun 2021
4SC AG: Developing innovative drugs for cancer patients
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on product development in oncology.
We develop novel small molecule drugs for the treatment of cancer in indications with a high unmet medical need and significant economic potential.
We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.